In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Innate Pharma S.A.

http://www.innate-pharma.com/

Latest From Innate Pharma S.A.

J&J-Bound Reed Reaches End Of The Road As Sanofi R&D Chief

The French drugmaker has begun an external and internal search to succeed John Reed who is heading for Johnson & Johnson after an up-and-down five years as Sanofi’s R&D chief.

Executive Changes Business Strategies

AstraZeneca Pulls Plug On Lumoxiti Due To Low Uptake

Signs of trouble were already emerging in 2020 when Innate backed out of a co-commercialization pact. AstraZeneca plans to discontinue the hairy cell leukemia ADC in July.

Business Strategies Cancer

Sanofi Gains New Innate Program In Expanded Collaboration

Deal Snapshot: Innate will receive 25m up front from Sanofi for an exclusive license to a new natural killer (NK) cell engager program and options to two additional targets.

Deals Cancer

Lacutamab Data Boost Prospects For Innate Pharma

The French biotech has presented positive Phase II data on lacutamab in mycosis fungoides at the EORTC-CLTG meeting in Madrid which looks to have de-risked the asset.

Cancer Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
UsernamePublicRestriction

Register